A distance difference matrix approach to identifying transcription factors that regulate differential gene expression by De Bleser, Pieter et al.
Genome Biology 2007, 8:R83
c
o
m
m
e
n
t
r
e
v
i
e
w
s
r
e
p
o
r
t
s
d
e
p
o
s
i
t
e
d
 
r
e
s
e
a
r
c
h
r
e
f
e
r
e
e
d
 
r
e
s
e
a
r
c
h
i
n
t
e
r
a
c
t
i
o
n
s
i
n
f
o
r
m
a
t
i
o
n
Open Access 2007 De Bleser et al. Volume 8, Issue 5, Article R83 Method
A distance difference matrix approach to identifying transcription 
factors that regulate differential gene expression
Pieter De Bleser*†‡, Bart Hooghe*†‡, Dominique Vlieghe*†‡ and Frans van 
Roy†‡
Addresses: *Bioinformatics Core, VIB, B-9052 Ghent, Belgium. †Department for Molecular Biomedical Research, VIB, B-9052 Ghent, Belgium. 
‡Department of Molecular Biology, Ghent University, B-9052 Ghent, Belgium. 
Correspondence: Pieter De Bleser. Email: pieterdb@dmbr.UGent.be
© 2007 De Bleser et al.; licensee BioMed Central Ltd. 
This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which 
permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Identifying transcription factor binding sites <p>A distance difference matrix method is presented for identifying transcription factor binding sites of secondary factors responsible for  the different responses of the target genes of one transcription factor.</p>
Abstract
We introduce a method that considers target genes of a transcription factor, and searches for
transcription factor binding sites (TFBSs) of secondary factors responsible for differential responses
among these targets. Based on the distance difference matrix concept, the method simultaneously
integrates statistical overrepresentation and co-occurrence of TFBSs. Our approach is validated on
datasets of differentially regulated human genes and is shown to be highly effective in detecting
TFBSs responsible for the observed differential gene expression.
Background
Eukaryotic genes are transcriptionally regulated by the coor-
dinated interaction of multiple transcription factors with
arrays of transcription factor binding sites (TFBSs) and with
each other. Arrays of TFBSs, referred to as cis-regulatory
modules (CRMs) [1,2], are usually situated upstream of the
genes they regulate. A simple strategy, based on the assump-
tion that co-expression implies co-regulation, is to identify
co-expressed genes by cluster analysis of their expression
data, followed by a search of their genomic sequences for
motifs that are statistically overrepresented. Such overrepre-
sented sequences are then considered to be potential TFBSs
[3-5]. This approach, however, does not take into account the
combinatorial nature of transcriptional regulation. An early
attempt to identify CRMs was undertaken by Pilpel et al. [6],
who demonstrated in yeast that genes whose promoters share
pairs of TFBSs are significantly more likely to be co-expressed
than genes whose promoters have only single TFBSs in com-
mon. The idea of finding combinations of motifs that best
explain the observed expression data has been developed fur-
ther [7-9].
In the present study, instead of considering CRMs them-
selves, we focused on those context-dependent TFBS interac-
tions that may explain why a change in a given signal
transduction pathway modifies the expression of genes in dif-
ferent directions, for example, up-versus down-regulation.
For this purpose, we built upon the distance difference matrix
concept that has been applied with great success in the field
of structural biology. This concept uses a distance difference
matrix (DDM) to compare two protein structures, such as
those encountered in studies of complexes and mutants [10].
The DDM contains all the distance difference (DD) values,
resulting from the subtraction of the corresponding elements
in the two distance matrices (DMs). Such a DM represents a
protein structure by the distances between the Cα-atoms of
every possible pair of the amino acids common to both pro-
tein structures being compared. Only where the two protein
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structures are different do the corresponding DD values devi-
ate from zero, which highlights the structural differences.
We use the above-described DDM concept to represent each
of the two promoter sets of differentially regulated genes as a
data structure summarizing all its TFBS associations. By cal-
culating the DDM and performing multidimensional scaling
(MDS) on it, we can distinguish between TFBSs that are not
likely to contribute to the observed differential gene expres-
sion and 'deviating' TFBSs that are likely responsible for the
observed differential gene expression.
Results
Overall strategy
The basic and intuitive idea of the DDM-MDS approach is
illustrated in Figure 1. Assuming the availability of two sets of
promoters of differentially regulated genes, it can be expected
that their responsiveness to a given stimulus can be explained
by TFBSs shared by both sets of promoters, though this may
not explain the direction of the response. Next to this com-
mon set of TFBSs, every set of promoters might bear one or
more TFBSs that are more characteristic of the promoters of
the up-regulated or of the down-regulated group of genes,
and might explain, at least partially, the observed differential
behavior. These 'differential' TFBSs can be found using the
following procedure. First, every promoter of each set is used
as input for the Match™ program [11], or any other similar
program, which will predict TFBSs on it using a precompiled
library of positional weight matrices (PWMs). The results,
being the number of predicted TFBSs per PWM per promoter
(further referred to as counts), are collected in the form of a
matrix in which each row corresponds to a promoter
sequence while the columns correspond to the used PWM.
The columns are further referred to as PWM-vectors, charac-
terizing a PWM by its number of predicted TFBSs per pro-
moter. (Figure 1a). Our choice for using the total number of
predicted TFBSs per PWM per promoter is motivated by the
observation of Papatsenko et al. [12] that regulatory regions
of  Drosophila melanogaster contain multiple copies of
robust motifs as well as weaker copies. In general, it is reason-
able to assume that the presence of multiple binding sites for
a transcription factor plays an important role. As our method
considers both overrepresentation and association, consider-
ing multiple matches per promoter may help discover puta-
tive functional TFBSs by overrepresentation. Two TFBSs are
considered correlated if their corresponding columns in the
matrix are similar. Similarity between the columns can be
measured using a distance function. With this approach, dis-
tance matrices summarizing all TFBS associations are con-
structed for the TFBSs in both sets of promoters (Figure 1b).
Finally, by calculating the DDM (Figure 1c) and performing
MDS on this matrix to visualize its content in two dimensions,
we can distinguish TFBSs that do not contribute to the
observed differential gene expression, as they will be mapped
near the origin of the DDM-MDS plot, from 'deviating' TFBSs
that are likely responsible for the observed differential gene
expression (Figure 1d). As the MDS procedure will plot TFBSs
that are strongly associated closer together than less associ-
ated ones, it highlights most of the otherwise often fuzzy
interactions between TFBSs in the promoter datasets.
The rationale behind this procedure is based on association
and individual overrepresentation (of one condition com-
pared to the other). Important modules in one condition but
not the other will be characterized by the overrepresentation
of their consisting TFBSs and will be associated. This results
in low DD values for two associated TFBSs, whereas the DD
value for a TFBS that is overrepresented and common TFBSs
will be high. Whether the TFBSs (and module) is typical for
either the first or the second set of promoters can be derived
from the sign of the column value sum of the original DDM.
The plot for an artificial example is shown in Figure S1 (in
Additional data file 1). In a background of counts for all
PWMs for two sets of randomly created promoters, two mutu-
ally exclusive modules of three TFBSs were inserted into the
first set and one module of three TFBSs was inserted into the
second set. The modules appear clearly separated from the
irrelevant TFBSs.
Principle of the DDM-MDS approach Figure 1 (see following page)
Principle of the DDM-MDS approach. A color code is consistently used in this Figure to indicate the status of the TFBSs predicted by a PWM. In the first 
set of promoters a CRM of three TFBSs is present (reddish), whereas the second set of promoters contains a CRM of two TFBSs (greenish). TFBSs not 
relevant for the differential expression between the genes corresponding to the two promoter sets are indicated in gray. (a) Two matrices, each of which 
contains the numbers of predicted TFBSs per PWM and per promoter (counts) for one set of promoters of differentially regulated genes. These counts 
are obtained by scanning the promoters with a precompiled library of PWMs. The number of promoters in both sets is the same in this artificial example, 
but does not need to be (see normalization in Materials and methods). Two PWMs are considered associated on the TFBS level if their corresponding 
columns (PWM-vectors) in the matrix are similar. This similarity can be measured using a distance function. (b) Distance matrices summarizing all PWM 
associations are constructed in both sets of promoters. (c) Subtraction of those distance matrices gives the DDM. PWMs predicting TFBSs in both 
promoter sets to the same amount (false positives as well as true positives: gray) and hence not involved in differential expression will show low DD 
values among each other. The DD values among the PWMs with associated and overrepresented TFBS predictions (greenish and reddish) will be just as 
low, but the DD values between those PWMs and the non-involved ones will be much higher (c). By performing MDS on the DDM, we can map the 
PWMs onto two-dimensional space and distinguish PWMs whose TFBSs are not contributing to the observed differential gene expression, as they will be 
mapped on the origin, from 'deviating' PWMs whose TFBSs are likely responsible for the observed differential gene expression. (d) The DDM-MDS plot 
clusters PWMs whose predicted TFBSs are strongly associated closer together than PWMs with less associated predicted TFBSs.http://genomebiology.com/2007/8/5/R83 Genome Biology 2007,     Volume 8, Issue 5, Article R83       De Bleser et al. R83.3
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Figure 1
(a) PWM
promoter
1 2 3 4 5 6 7 ...p
1-1 3 1 4 1 3 11
1-2 4 0 3 1 3 00
1-3 4 0 3 0 4 01
1-4 4 1 4 1 4 11
1-5 4 0 4 0 4 00
1-6 4 0 4 1 3 11
1-7 4 0 3 1 4 10
1-8 4 1 4 0 4 01
1-9 3 1 3 0 4 00
1-10 3 1 4 1 4 11
PWM
promoter
1 2 3 4 5 6 7 ...p
2-1 0 4 11114
2-2 0 4 11103
2-3 1 4 10004
2-4 1 4 00013
2-5 1 4 00014
2-6 1 4 01113
2-7 1 3 11104
2-8 0 3 10003
2-9 0 4 10014
2-10 1 3 10014
(b) 1 2 3 4 5 6 7 ...p
1 0.00
2 10.4 0.00
3 2.24 9.95 0.00
4 10.0 2.24 9.70 0.00
5 2.00 10.3 2.24 10.1 0.00
6 10.3 2.00 9.95 1.00 10.3 0.00
7 10.0 1.73 9.59 2.00 10.0 1.73 0.00
.. .p
1 2 3 4 5 6 7 ...p
1 0.00
2 10.0 0.00
3 2.65 9.80 0.00
4 2.45 10.6 2.24 0.00
5 2.45 10.6 2.24 1.41 0.00
6 2.00 9.95 2.65 2.45 2.45 0.00
7 9.70 2.24 9.33 10.3 10.3 9.70 0.00
(c) 1 2 3 4 5 6 7 ...p
1 0.00
2 0.44 0.00
3 -0.41 0.15 0.00
4 7.60 -8.39 7.46 0.00
5 -0.45 -0.33 0.00 8.73 0.00
6 8.39 -7.94 7.30 -1.45 7.94 0.00
7 0.35 -0.50 0.26 -8.39 -0.25 -7.96 0.00
...p
(d)
.. .p .. .pR83.4 Genome Biology 2007,     Volume 8, Issue 5, Article R83       De Bleser et al. http://genomebiology.com/2007/8/5/R83
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TFBS-specific significance calculation
Using the DDM-MDS protocol, we calculate the distance
between the origin of the DDM-MDS plot and each mapped
TFBS. A P value is associated with this distance using the fol-
lowing procedure. We constructed 10,000 sets of two groups
of randomly selected promoter sequences from the human
genome; the sizes of the groups and lengths of constituting
promoter sequences reflected the dataset under study. The
DDM-MDS procedure was applied to the random sets. The
distances obtained with each PWM in the null model follow a
gamma distribution, the shape of which depends upon the
PWM used. As an example, the distances obtained with the
V$CEBPB_01 PWM and the V$E2F1_Q3 PWM using the null
model are given in Figures S2 and S3 (in Additional data file
2), respectively. Fitting of the distance distribution was per-
formed using the 'fitdistr' command of the R package 'MASS'
[13] and the goodness-of-fit were evaluated using the Kol-
mogorov-Smirnov test. Finally, since one P value is calculated
for each PWM, a correction for multiple testing becomes nec-
essary. We employ the concept of false discovery rates
(FDRs), which allows us to adjust the size of our result set as
a function of the number of false discoveries we allow.
Although the significance calculation of the MDS-distance is
done per PWM, there is apparently a close correlation
between the increase in distance from the origin of the DDM-
MDS plot to the mapped TFBS and the statistical significance
of the observation.
Validation using biological datasets
Typical DDM-MDS plots using 800 base-pair (bp) upstream
promoter sequences can be found in Figures 2 and 3. Every
dot corresponds to one PWM from the TRANSFAC 8.4 Pro-
fessional Motif library. The parameters for Match to obtain
the number of predicted TFBSs per PWM were set to 0.9 for
core similarity and 0.75 for matrix similarity. These are rela-
tively relaxed threshold values that reduce false negatives
while increasing false positives. This should be viewed in the
context of our interest in the logical relationships between the
matched sites.
Examples of logical relationships are: AND logic, multiple
required binding sites; OR logic, a set of motifs any of which
satisfies a binding site; and NOT logic, a binding site that
should not be present [14]. The prediction of TFBSs is the first
step in our approach, and it is crucial that the logical relation-
ships between TFBSs are not lost from the beginning. For
instance, if the threshold value is set very high to minimize
the number of false positives, a maximum of false negatives
having a count of zero will be recorded in the input matrices.
This would break the AND logical aspects eventually being
present between high scoring binding sites and those that
score moderately, falling below the threshold score used. The
increase in false positive predictions is not a big problem
because they participate in random associations in both sets
of promoters; as a result, their PWM will be mapped around
the origin in the DDM-MDS plot. This is illustrated in the arti-
ficial example shown in Figure S1 (Additional data file 1) as
the orange cloud of irrelevan t  P W M s  m a p p e d  a r o u n d  t h e
origin.
DDM-MDS plot of the TFBS associations found in the E2F dataset Figure 2
DDM-MDS plot of the TFBS associations found in the E2F dataset. Every 
dot corresponds to a specific PWM from the TRANSFAC 8.4 Professional 
Motif library. The parameters for Match were set to 0.9 for core similarity 
and 0.75 for matrix similarity. Most of the PWMs were mapped around 
the origin, indicating that they are either common to either dataset or that 
they participate in random TFBS associations. The color of the dot 
indicates whether the TFBS participates more in associations found in 
promoters of up-regulated genes (red) or down-regulated genes (green). 
Associated with up-regulation (red), we find binding sites for E2F, ZF5, AP-
2alpha and AP-2gamma. Associated with down-regulation, we find binding 
sites for several CEBPs, STATs and HNFs.
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DDM-MDS plot of the TFBS associations found in the p53 dataset Figure 3
DDM-MDS plot of the TFBS associations found in the p53 dataset. 
Associated with up-regulation we find binding sites for several CEBPs, 
STATs and HNFs. Associated with down-regulation we observe binding 
sites for E2F, ZF5 AP-2alpha and AP-2gamma. The parameters for Match 
were set to 0.9 for core similarity and 0.75 for matrix similarity. See Figure 
2 for the procedure followed.
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For the biological datasets, most of the PWMs were mapped
around the origin, indicating that they are irrelevant for the
observed differential expression. The further away a PWM is
located from the origin, the stronger the individual overrep-
resentation of the corresponding TFBSs in one group of
promoters compared to the other. The greater the degree of
association of TFBSs, the more closely their PWMs will be
plotted together. The color of the dot indicates whether the
TFBSs corresponding to the PWM are overrepresented in
promoters of up-regulated genes (red, positive sum of DD val-
ues) or down-regulated genes (green, negative sum of DD val-
ues). We also considered the presence of repetitive elements.
These elements may contain potential transcriptional regu-
lating signals and, therefore, may be relevant to transcrip-
tional regulation. We therefore ran the DDM-MDS analysis
with both masked and unmasked promoter sequences. The
results are shown in Figures S4 and S5 (in Additional data file
3). In these particular cases, the effects of masking repeat
sequences are only marginal, indicating that repetitive ele-
ments are not involved in regulating the observed differential
gene expression. With respect to the chosen length of the pro-
moters of 800 bp, most known TFBSs in TRANSFAC have
preferred locations between -300 and +50 bp relative to the
transcription start site (TSS) [15]. This implies that the basal
promoter and nearby upstream regulatory elements are
found in this region, which is in agreement with the findings
of a previous study [16]. That study, using a luciferase-based
transfection assay in four human cultured cell types, found
that 91% of 152 DNA fragments containing regions -550 to
+50 relative to the TSS were transcriptionally active. Includ-
ing an excessive amount of irrelevant sequence would add
noise to our approach, and 800 bp upstream of the TSS may
provide a reasonable balance between signal and noise in
most of the cases. In order to evaluate the effect of taking
longer upstream promoter sequences, we compared the
results of the DDM-MDS analyses obtained with the 800 bp
and 1,500 bp upstream promoter regions of the E2F (Figure
S7) and p53 (Figure S8) datasets (see Additional data file 6).
The overall pictures remain similar: the main TFBSs appear
in positions relatively conserved with respect to the origin of
the plot and to each other.
Promoters of the human p16INK4A-pRB-E2F pathway
Vernell et al. [17] identified 97 genes as physiological targets
of the p16INK4A-pRB-E2F pathway. Of these, a set of 74 genes
is repressed by pRB and p16, but induced by E2F. Another set
of 23 genes is induced by pRB and p16, but repressed by E2F.
The promoters of the genes that were annotated as known tar-
get genes in the published dataset were compiled in a dataset
of 18 promoters of genes that are up-regulated by E2F and
down-regulated by pRB and p16, and another dataset of 17
promoters of genes that are down-regulated by E2F and up-
regulated by pRB and p16.
Figure 2 shows the DDM-MDS plot of the TFBS associations
found in this dataset, and Tables 1 and 2 list the highest scor-
ing PWMs whose predicted TFBSs are associated with the
promoters of up- and down-regulated target genes, respec-
tively. Associated with up-regulation (red) we find binding
sites for E2F, ZF5, AP-2alpha and AP-2gamma. Associated
with down-regulation we find binding sites for several CEBPs,
STATs, HNFs and AP3.
Promoters of human p53 target genes
Using DNA microarrays, Kannan et al. [18] selected 38 and
24 primary targets that were, respectively, up- and down-reg-
ulated upon activation of the temperature-sensitive murine
p53 in a human lung cancer cell line. Promoter sequences of
genes that could be unambiguously identified were collected
and used in this analysis. This yielded a dataset of 17 promot-
ers of genes that are up-regulated by p53 and 14 promoters of
genes that are down-regulated by p53.
The results of the DDM-MDS analysis are shown in Figure 3.
In the set of promoters of up-regulated genes, we find binding
sites for several CEBPs, HNFs and STATs, while in the set of
promoters of down-regulated genes we observe binding sites
for E2F, ZF5 AP-2alpha and AP-2gamma. Table 3 (promoters
of up-regulated target genes) and Table 4 (promoters of
down-regulated target genes) show the lists of the PWMs with
the strongest associations with the observed expression.
Promoters of human c-MYC target genes
Coller  et al. [19] identified by oligonucleotide microarray
analysis a set of genes that were either consistently induced or
consistently repressed upon activation of c-MYC in primary
human fibroblasts. The 800 bp human genomic sequences
upstream of the genes listed in this dataset were collected.
This yielded 28 promoters of genes that were up-regulated
and 8 promoters that were down-regulated upon c-MYC
activation.
Supplemental Figure S6 (in Additional data file 4) shows the
result of the DDM-MDS procedure. Associated with up-regu-
lation we find binding sites for MYC, STAT3, MZF-1 and
ARNT. Associated with down-regulation, binding sites for
STATx, CdxA and Sp1 are found. The PWMs whose TFBSs
show the strongest associations with the observed expression
are shown in Tables S1 and S2 (in Additional data file 4).
Promoters of human E2F and p53 target genes are 
inversely regulated
When we compare the TFBSs associated with differential up-
regulation of E2F target genes (Table 1) with those associated
with differential down-regulation of p53 target genes (Table
4), we find binding sites for AP-2alpha, AP-2gamma, CHCH,
pRb:E2F-1:DP-1, E2F-1:DP-1, E2F-1, c-Myc:Max, Sp1 and
ZF5 in both sets of promoters. An overlapping subset of
TFBSs is also found when comparing the TFBSs associated
with differential down-regulation of E2F target genes (Table
2) with those associated with differential up-regulation of p53R83.6 Genome Biology 2007,     Volume 8, Issue 5, Article R83       De Bleser et al. http://genomebiology.com/2007/8/5/R83
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target genes (Table 3). This subset comprises binding sites for
AP-3, C/EBPalpha, C/EBPbeta, IRF, STAT4 and STAT6.
The inverse relationships between the two datasets became
clearer when we looked at the DDM-MDS plots for these data-
sets, as shown in Figures 2 and 3. As the MDS procedure plots
strongly associated TFBSs closer together than less associ-
ated ones, the fuzzy interactions between TFBSs in the data-
sets are visualized as recognizable patterns. For both
datasets, two clusters of TFBS associations emerge: one cor-
responds to up-regulated gene-TFBS associations (more red)
and another to down-regulated gene-TFBS associations
(more green). While the positions of the common aforemen-
tioned TFBSs in each cluster are relatively conserved, the
main difference between them in the two clusters of each
dataset is their inverse color. TFBSs characteristic of up-reg-
ulation in the E2F dataset are characteristic of down-regula-
tion in the p53 dataset, and vice versa.
Comparison to alternative methods
We compared our DDM-based method to several methods
that claim to be able to find the TFBSs or CRMs responsible
Table 1
TFBSs associated with differential up-regulation of E2F target genes
Identifier P value Q-value Factor name Reference
V.E2F_Q6 0.000 0.000 E2F [25-27]
V.E2F1_Q3 0.000 0.000 E2F-1 [22,25-27]
V.E2F1_Q6 0.000 0.000 E2F-1 [22,25-27]
V.E2F1DP1_01 0.000 0.000 E2F-1:DP-1 [25-27]
V.E2F4DP1_01 0.000 0.000 E2F-4:DP-1 [61]
V.E2F1DP1RB_01 0.000 0.000 E2F-1:DP-1 [25-27]
V.CHCH_01 0.000 0.000 ChCh
V.E2F4DP2_01 0.000 0.019 E2F-4:DP-2 [61]
V.E2F_03 0.001 0.029 E2F [25-27]
V.E2F_Q2 0.001 0.029 E2F [25-27]
V.AP2ALPHA_02 0.001 0.036 AP-2alpha [28,29]
V.MYCMAX_B 0.002 0.049 Myc/max [62]
V.ZF5_B 0.002 0.049 ZF5 [22]
V.E2F1DP2_01 0.002 0.049 E2F-1:DP-2 [22,25-27]
V.AP2GAMMA_01 0.003 0.052 AP-2gamma [28,29]
V.CETS1P54_01 0.004 0.060 c-Ets-1 [35]
V.AP2ALPHA_01 0.005 0.075 AP-2alpha [28,29]
V.SRF_Q4 0.005 0.075 SRF
V.GLI_Q2 0.006 0.078 GLI
V.E2F_Q3 0.007 0.087 E2F [22,25-27]
V.SRF_Q5_01 0.009 0.098 SRF
V.PAX4_01 0.009 0.100 Pax-4a
V.FOXO4_02 0.011 0.103 FOXO4 [63]
V.AFP1_Q6 0.011 0.103 AFP1
V.EGR2_01 0.012 0.104 EGR-2
V.ZF5_01 0.012 0.106 ZF5 [22]
V.SPZ1_01 0.013 0.106 Spz1
V.SP1_01 0.023 0.143 Sp1 [30-34]
V.ELK1_02 0.026 0.143 Elk-1
V.E2_Q6 0.026 0.143 E2
V.GC_01 0.028 0.143 GC box
V.WHN_B 0.023 0.143 Whn [22]
V.ETF_Q6 0.028 0.143 ETF [64]
V.EBF_Q6 0.030 0.144 EBF
V.SP1_Q4_01 0.032 0.145 Sp1 [30-34]
Transcription factors for which common TFBS associations are found in the promoters of down-regulated p53 target genes are indicated in bold. 
Results are sorted by Q-value.http://genomebiology.com/2007/8/5/R83 Genome Biology 2007,     Volume 8, Issue 5, Article R83       De Bleser et al. R83.7
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for the difference in the response to a stimulus. Since the
results of the comparisons are not useful due to the largely
disappointing results of the other methods, notes and data
about the considered and executed methods can be found in
the Additional data files.
In short, LogicMotif [20] and CMA [21] effectively produced
some results, but they turned out to be of limited use. These
results are given in Tables S3 and S4 (in Additional data file
5), respectively. CREME [22] did not find any module. The
output of POCO [23], consisting of five lists of short
sequences representing overrepresented TFBSs, is not
directly comparable with the output of our approach because
our approach takes into account the associations between
TFBSs and works only with TFBSs for known transcription
factors. CLOVER [24], another program that seeks only for
individually overrepresented TFBSs in a promoter set, but in
a quite original way, was also compared to our method.
Discussion
We applied our DDM-based method to the dataset of differ-
entially regulated human target genes of the p16INK4A-pRB-
E2F pathway. Associated with the up-regulated E2F target
genes we found the expected E2F binding sites that have been
described for this dataset [17], and also other sites, including
AP2 and Sp1. Functional synergism between E2F sites was
demonstrated in several promoters [25-27]. Functional Sp1
and AP2 sites were identified in the promoter of the von Hip-
pel-Lindau (VHL) tumor suppressor gene [28], a known E2F
target gene [29]. Functional cooperation between E2F and
Sp1 was reported in several cell-cycle-related promoters [30-
34]. Functional co-occurrence of E2F and c-Ets-1 was demon-
strated in the promoter of the mouse gamma-glutamyl hydro-
lase (gamma GH) gene [35]. As for TFBSs associated with
down-regulated E2F target genes, we found among others
sites for STAT6, IRF2 and C/EBP. Functional co-occurrence
of E2F and IRF2 has been demonstrated in the mouse tapasin
promoter [36]. The presence of STAT6 binding sites is partic-
Table 2
TFBSs associated with differential down-regulation of E2F target genes
Identifier P value Q-value Factor name Reference
V.CEBPB_01 0.000 0.000 C/EBP [39]
V.CEBP_C 0.000 0.010 C/EBP [39]
V.CDPCR3_01 0.001 0.026 CDP CR3
V.AP3_Q6 0.002 0.043 AP3
V.STAT4_01 0.003 0.049 STAT4
V.SMAD4_Q6 0.003 0.049 SMAD-4 [65]
V.AREB6_04 0.005 0.075 AREB6
V.CEBPA_01 0.006 0.078 C/EBP [39]
V.GEN_INI3_B 0.009 0.102 GEN_INI
V.PADS_C 0.011 0.103 PADS
V.GEN_INI2_B 0.011 0.103 GEN_INI
V.GEN_INI_B 0.011 0.103 GEN_INI
V.PAX2_02 0.013 0.106 PAX2
V.LDSPOLYA_B 0.015 0.110 Poly A
V.IRF_Q6 0.018 0.130 IRF [36]
V.CEBP_Q2 0.020 0.137 C/EBP [39]
V.CEBP_01 0.029 0.143 C/EBP [39]
V.AP1FJ_Q2 0.027 0.143 AP-1 [66]
V.ETS1_B 0.029 0.143 c-Ets-1 [67]
V.DBP_Q6 0.027 0.143 DBP
V.FOXM1_01 0.027 0.143 FOXM1 [68]
V.CEBP_Q3 0.028 0.143 C/EBP [39]
V.HELIOSA_02 0.024 0.143 HELIOS
V.PIT1_Q6 0.030 0.144 Pit-1
V.AP1_01 0.033 0.146 AP-1 [66]
V.BARBIE_01 0.035 0.150 Barbie box
V.STAT6_01 0.035 0.150 STAT6 [38]
V.AP1_Q2 0.036 0.151 AP-1 [66]
Transcription factors for which common TFBS associations are found in the promoters of up-regulated p53 target genes are indicated in bold. 
Results are sorted by Q-value.R83.8 Genome Biology 2007,     Volume 8, Issue 5, Article R83       De Bleser et al. http://genomebiology.com/2007/8/5/R83
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ularly interesting: specific E2F heterocomplexes and com-
plexes with RB prefer to bind to a palindromic consensus
binding site of the type TT(c/g)(c/g)CGC(c/g)AA[37]. This
type of palindromic E2F site is similar to TTCNNNNGAA, the
binding site for STAT6. Inversely, it has been demonstrated
that STAT6 binds to a subset of E2F sites [38]. C/EBP inhibits
E2F-driven gene expression in liver [39].
For the dataset of human p53 target genes [18], our distance
difference matrix analysis revealed binding sites associated
with up-regulation of p53 target genes, including GATA-1 and
STAT5A. Physical co-occurrence of a binding site for GATA-1
and p53 has been demonstrated in the promoter of human
Wnt2 [40]. For STAT5, it has been shown that p53
counteracts STAT5 mediated cytokine induction of gene tran-
scription [41]. Regarding TFBSs associated with down-regu-
Table 3
TFBSs associated with differential up-regulation of p53 target genes
Identifier P value Q-value Factor name Reference
V.P300_01 0.001 0.032 P300 [69]
V.GATA1_01 0.000 0.032 GATA-1 [40]
V.CEBPA_01 0.001 0.032 C/EBP
V.CEBP_01 0.000 0.032 C/EBP
V.AP3_Q6 0.000 0.032 AP3
V.GATA2_01 0.004 0.047 GATA-2 [70]
V.CEBPB_01 0.004 0.047 C/EBP
V.HNF4_Q6 0.004 0.048 HNF4 [71]
V.CDPCR3HD_01 0.005 0.052 CDP CR3
V.STAT6_01 0.005 0.052 STAT6
V.CEBP_Q2 0.005 0.052 C/EBP
V.STAT5A_03 0.008 0.058 STAT5A [41]
V.MYOGENIN_Q6 0.010 0.058 myogenin
V.POU1F1_Q6 0.011 0.063 POU1F1
V.STAT_Q6 0.011 0.063 STAT [72]
V.GEN_INI3_B 0.013 0.063 GEN_INI
V.GEN_INI_B 0.012 0.063 GEN_INI
V.CEBP_Q3 0.013 0.064 C/EBP
V.GEN_INI2_B 0.015 0.069 GEN_INI
V.TTF1_Q6 0.016 0.073 TTF-1
V.OCT_Q6 0.017 0.074 Oct
V.HMGIY_Q3 0.018 0.074 HMG IY [73]
V.CAP_01 0.019 0.077 cap
V.MYOD_Q6 0.020 0.078 MyoD
V.FAC1_01 0.020 0.078 FALZ
V.E2A_Q2 0.021 0.078 E2A [74]
V.GATA1_02 0.022 0.081 GATA-1 [40]
V.E2A_Q6 0.023 0.081 E2A [74]
V.HMGIY_Q6 0.026 0.088 HMG IY [73]
V.IRF1_Q6 0.027 0.090 IRF
V.FOXD3_01 0.030 0.094 FOXD3
V.HNF3ALPHA_Q6 0.030 0.094 HNF-3alpha
V.E47_01 0.032 0.096 E47
V.BARBIE_01 0.032 0.096 Barbie box
V.HNF3B_01 0.033 0.097 HNF-3beta
V.HOXA3_01 0.034 0.097 HOXA3
V.HNF3_Q6 0.038 0.101 HNF-3
V.STAT4_01 0.040 0.102 STAT4
Transcription factors for which common TFBS associations are found in the promoters of down-regulated E2F target genes are indicated in bold. 
Results are sorted by Q-value.http://genomebiology.com/2007/8/5/R83 Genome Biology 2007,     Volume 8, Issue 5, Article R83       De Bleser et al. R83.9
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lated p53 target genes, we found sites for Sp1, AP2, c-Myc and
E2F. Transcriptional repression of the protein kinase Calpha
by p53 via Sp1 is involved in inhibiting phosphorylation of
multidrug resistance-1 P-glycoprotein [42]. Functional co-
occurrence of p53 and AP2 binding sites has been demon-
strated in the promoter of KAI1 [43]. Functional co-occur-
rence of Myc and p53 has been demonstrated in the promoter
of PDGF beta-receptor, a p53 target gene [44]. Functional
E2F binding sites are present on the promoter of the human
ARF cell cycle regulatory gene, also a p53 target gene [45].
The analysis of the dataset of c-MYC human target genes [19]
yields expected results. We find binding sites for several tran-
scription factors, including MYC, STATx, ARNT and
AHRHIF, associated with up-regulated c-MYC target genes.
The promoter of MT-MC1, a direct c-Myc target gene, has
been shown to contain multiple Myc consensus sites [46].
Functional cooperation between USF and c-Myc was demon-
strated in the regulation of expression of CDK4, a known
direct target of c-Myc [47]. Associated with down-regulation,
binding sites for STATx, CdxA, NFAT and PAX2 are found.
The PWMs whose TFBSs show the strongest associations
with the observed expression are shown in Tables S1 and S2
(in Additional data file 4).
An important feature of the DDM-MDS procedure is that the
greater the degree of association of TFBSs, the closer together
they will be plotted in the final DDM-MDS plot. Conse-
quently, the interactions in the datasets are visualized in the
plots as clustered TFBS sets. In that way, functionally related
datasets will be easily recognized by comparing their associa-
tion plots. This is illustrated for the E2F and p53 promoter
datasets (Figures 2 and 3), which originate from different lab-
oratories and have only one gene in common (CCNE1), but
whose DDM-MDS plots are remarkably similar. Apparently,
the promoters of the two datasets share a subset of TFBS
associations. The main difference is that the subsets of TFBS
associations that are characteristic of up-regulation in the
E2F dataset are characteristic of down-regulation in the p53
dataset, and vice versa. Both E2F and p53 play important
roles in controlling the cell cycle. E2F proteins are implicated
in promoting the S phase of the cell cycle, whereas the p53
tumor suppressor protein can arrest cells in G1 phase, and
thereby prevent entry into S phase [48]. However, the mech-
anisms coupling the p53 and E2F pathways are not fully
understood. Based on our results, we suggest that this differ-
ential behavior is encoded directly in the promoters of the
E2F and p53 target genes in the form of characteristic second-
ary factor binding sites. Our method alone cannot predict
whether these secondary factors actually interact with E2F
and/or p53 proteins on the promoter level, but it generates a
hypothesis that can then be validated experimentally.
Conclusion
We propose a new method for identifying context-dependent
interactions between TFBSs that may explain the different
directions in the context-specific gene expression. Our
approach is inspired by the DDM concept used in structural
biology, and it implicitly looks at TFBS associations and not
only at the overrepresentation of a TFBS by itself. We never
lose the association information between TFBSs, and the
Table 4
TFBSs associated with differential down-regulation of p53 target genes
Identifier P value Q-value Factor name Reference
V.MYCMAX_B 0.000 0.032 Myc/Max [44]
V.E2F_Q2 0.001 0.032 E2F [45]
V.CHCH_01 0.004 0.047 ChCh
V.E2F_03 0.004 0.048 E2F [45]
V.E2F1_Q6 0.006 0.057 E2F-1 [45]
V.AP2_Q6 0.008 0.058 AP2 [42]
V.E2F1_Q3 0.007 0.058 E2F-1 [45]
V.ZF5_01 0.009 0.058 ZF5
V.ZF5_B 0.011 0.062 ZF5
V.SP1_01 0.017 0.074 Sp1 [42]
V.AP2GAMMA_01 0.021 0.078 AP-2gamma [43]
V.AP2ALPHA_02 0.024 0.083 AP-2alpha [75]
V.AP2_Q3 0.027 0.090 AP2 [42]
V.E2F1DP1_01 0.032 0.096 E2F1:DP1 [45]
V.MZF1_02 0.037 0.101 MZF-1
V.AP2ALPHA_01 0.045 0.106 AP-2alpha [75]
Transcription factors for which common TFBS associations are found in the promoters of up-regulated E2F target genes are indicated in bold. 
Results are sorted by Q-value.R83.10 Genome Biology 2007,     Volume 8, Issue 5, Article R83       De Bleser et al. http://genomebiology.com/2007/8/5/R83
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greater the association, the more closely they will be plotted
in the final DDM-MDS plot. Consequently, this will visualize
the often fuzzy interactions between the TFBSs in the data-
sets, leading to the formation of recognizable patterns in the
plots if the datasets are functionally related.
When we validated this approach on different datasets, we
were able to identify the main transcriptional regulators
described in the original papers and several others whose
possible involvement in the signal transduction pathway has
ample support in the literature. In addition, we found that the
same subset of TFBS associations that characterized up-regu-
lation of E2F target genes also characterized down-regulation
of p53 target genes, and vice versa. These observations may
at least partially explain the opposing functions that E2F and
p53 perform in the control of the cell cycle. This can be con-
sidered a strong validation of our analyses.
Compared to other methods, our method produces much
more reliable results. When suitable alternative methods are
applied to the above discussed datasets, either they suffer
from major random effects (LogicMotif), or they require the
setting of a large number of parameters of which the values
can not be estimated or known beforehand (CMA), or they
produce no results at all (CREME). In addition, our method is
the only one to visualize both the overrepresentation of
TFBSs and the associations between them in one informative
plot.
Finally, our method is generally applicable and we expect that
it may provide most instructive clues for experimental dissec-
tion of several gene regulatory pathways in higher eukaryotes.
Materials and methods
Datasets
The datasets of the promoters were constructed by extracting
nucleotide sequences spanning positions -800 to +0, and -
1,500 to +0 relative to the TSS, as reported in the NCBI refer-
ence sequences (RefSeq) record of their genes from the May
2004 (hg17) GenBank™ freeze, using the UCSC genome
annotation database [49]. RefSeq provides standards for
genomes, proteins and transcripts resulting from either man-
ual curation or computational gene predictions on pre-
assembled contigs [50]. In cases where genes had a RefSeq
status of at most 'predicted', an additional verification of the
TSS was performed using DBTSS (the DataBase of Transcrip-
tional Start Sites) [51].
Matrix representation of the TFBS-annotated 
promoter sequences
Upstream promoter sequences (number = n) are used as
input for the Match™ program [11], which predicts TFBSs on
these sequences making use of a precompiled library
containing p PWMs. The information of the annotated output
is then collected in the form of a data matrix (N) in which the
n rows correspond to the promoter instances and the p
columns to the PWMs (and hence their corresponding
TFBSs). Nij is the number of times a TFBS for PWM j was pre-
dicted in promoter sequence i.
Identification of transcription factor binding sites
Match distributed with the TRANSFAC Professional version
8.4 database [52] (Biobase Biological Databases) was used to
identify putative transcription factor binding sites within
each upstream sequence. As a precompiled library of motif
matrices, we used the subset of 512 vertebrate motifs from the
TRANSFAC Professional version 8.4 database. Before per-
forming the matrix search, the repetitive elements in the pro-
moter sequences can be optionally masked using 'CENSOR',
a program that makes use of 'Repbase Update', a database of
eukaryotic repetitive elements, to identify and eliminate
repetitive elements from DNA sequences [53,54].
Definition of the distance difference matrix
The overall strategy is shown in Figure S9 (in Additional data
file 7). Given an nA × p data matrix A, we are interested in the
distances between the p PWM-vectors that characterize this
particular set of nA promoter sequences. DA is the p × p dis-
tance matrix containing the distances DA
ij between PWM-vec-
tors i and j (i and j in [1, p]) from matrix A, normalized for the
number nA of promoters in A (using function f):
where A,i and A,j are columns i and j of matrix A, the PWM-
vectors i and j. We exclusively used the Euclidean distance as
a distance measure between PWM-vectors, hence the func-
tion f(x) equals  .
Given another nB × p data matrix B, the elements   of the
distance difference matrix DA - B are:
Based on the notion that two PWMs are correlated on the
TFBS level if their corresponding PWM-vectors in either DA
or DB are similar, it is clear that DA and DB contain informa-
tion about all the associations that exist between the different
PWMs in the sets of promoter sequences.
Multidimensional scaling
MDS [55] is a method for mapping a set of N objects to N
points in k-space such that a given set of target distances or
dissimilarities are approximated as well as possible. The pro-
cedure finds two-dimensional coordinates of the PWMs by
approximating the distance difference values of the DDM on
a two-dimensional scale. In the DDM-MDS plot the distance
to the origin is used as a relevance measure for each PWM,
and the distances between the 'PWM dots' on the plot tell us
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which TFBSs co-occur on the same promoters. Hence, MDS
helps us to determine which PWMs behave the most differ-
ently in the two compared promoter sets with respect to all
other PWMs. MDS was performed using the cmdscale com-
mand in R [13]. This function corresponds to an implementa-
tion of classical MDS (CMDS), also known as principal
coordinates analysis (PCO) or metric MDS. CMDS calculates
an eigenanalysis of the DDM to maximize variability along
axes. The largest variability is captured by the first two eigen-
values, which enables us to provide a global view of the
importance and interactions of the TFBSs in a two-dimen-
sional plot.
Estimation of P values
Our aim is to identify the TFBS associations responsible for
the observed differential gene expression. First, using the
DDM-MDS protocol, we calculate the distance between the
origin of the MDS plot and the mapped TFBS. This distance
quantifies the degree to which this TFBS participates differ-
ently in associations with other TFBSs. In the second step, a P
value is estimated for this distance. To this end, we define the
null hypothesis that the TFBSs do not participate in associa-
tions with other TFBSs. This requires specification of a prob-
abilistic model that will be used to estimate the probability
that this model generates a distance at least as large as the
observed distance. Randomness can be implemented in the
null model either by applying shuffling algorithms on the pro-
moter sequences themselves, or by taking randomly chosen
fragments or promoter sequences of the organism's genome.
In the present study, we opted for the latter because it may
reflect a more biologically adequate null model that takes into
account global promoter sequence parameters much more so
than randomly generated sequences. Since all TFBSs have
their particular behavior and are described by positional
weight matrices of different quality, we expect differences in
random distance distributions for each TFBS. Hence, the
DDM-MDS procedure was applied to 10,000 random sets
and the resultant distances from each mapped TFBS to the
origin of the DDM-MDS plot were obtained. Subsequently,
the P value of a real distance was calculated from the fraction
of the corresponding 'background distances' exceeding this
real distance.
Correction for multiple testing
To adjust for the multiple testing problem in our analysis, we
adopted the concept of the FDR introduced by Benjamini and
Hochberg [56]. FDR is defined as the fraction of significant
results that are likely due to chance. FDR can be estimated,
when calling all P values less than or equal to some threshold
t significant (0 < t ≤ 1), by TΦt/nt, where T is the number of
TFBS, Φt the expected proportion of false positive errors at
the specified significance level, and nt the number of signifi-
cant tests at that level. Storey and Tibshirani [57] provide an
automated way of estimating Φt from the observed P values.
We used the implementation of their approach in the R pack-
age 'GeneTS' [58].
Web server
The tool can be accessed at our web server [59]. The user can
submit data or try the datasets described in this paper. Three
matrix sets can be used to characterize the promoter regions
of interest: TRANSFAC8.4 [52], JASPAR CORE, or JASPAR
phyloFACTS [60]. This generates the DDM-MDS plot and a
set of two tables comprising the most significant transcription
factors that explain the differences in the datasets.
Additional data files
The following additional data are available with the online
version of this paper. Additional data file 1 is a DDM-MDS
plot of an artificial example, demonstrating the power of the
approach (Figure S1). Additional data file 2 shows two back-
ground distributions of the distance of a PWM to the origin of
the DDM-MDS plot, for two different PWMs, showing the dif-
ferent scales of the distributions (Figures S2 and S3). Addi-
tional data file 3 contains DDM-MDS plots showing the
minor effects of masking repeat sequences in the promoter
sequences on the results for the E2F and p53 datasets (Fig-
ures S4 and S5). Additional data file 4 provides DDM-MDS
results for the c-Myc dataset (Figure S6, Tables S1 and S2).
Additional data file 5 is a comparison of our DDM-MDS
approach with some of the available alternative methods:
CLOVER, LogicMotif, POCO, CREME, CMA (Tables S3 and
S4). Additional data file 6 is a comparison of the DDM-MDS
plots obtained with the 800 bp and 1,500 bp upstream pro-
moter regions of the E2F (Figure S7) and p53 (Figure S8)
datasets. Additional data file 7 is a calculation of the distance
difference matrix (Figure S9).
Additional data file 1 DDM-MDS plot of an artificial example, demonstrating the power  of the approach (Figure S1) DDM-MDS plot of an artificial example, demonstrating the power  of the approach (Figure S1). Click here for file Additional data file 2 Two background distributions of the distance of a PWM to the ori- gin of the DDM-MDS plot, for two different PWMs, showing the  different scales of the distributions (Figures S2 and S3) Two background distributions of the distance of a PWM to the ori- gin of the DDM-MDS plot, for two different PWMs, showing the  different scales of the distributions (Figures S2 and S3). Click here for file Additional data file 3 DDM-MDS plots showing the minor effects of masking repeat  sequences in the promoter sequences on the results for the E2F and  p53 datasets (Figures S4 and S5) DDM-MDS plots showing the minor effects of masking repeat  sequences in the promoter sequences on the results for the E2F and  p53 datasets (Figures S4 and S5). Click here for file Additional data file 4 DDM-MDS results for the c-Myc dataset (Figure S6, Tables S1 and  S2) DDM-MDS results for the c-Myc dataset (Figure S6, Tables S1 and  S2). Click here for file Additional data file 5 Comparison of our DDM-MDS approach with some of the available  alternative methods: CLOVER, LogicMotif, POCO, CREME, CMA  (Tables S3 and S4) Comparison of our DDM-MDS approach with some of the available  alternative methods: CLOVER, LogicMotif, POCO, CREME, CMA  (Tables S3 and S4). Click here for file Additional data file 6 Comparison of the DDM-MDS plots obtained with the 800 bp and  1,500 bp upstream promoter regions of the E2F (Figure S7) and  p53 (Figure S8) datasets Comparison of the DDM-MDS plots obtained with the 800 bp and  1,500 bp upstream promoter regions of the E2F (Figure S7) and  p53 (Figure S8) datasets. Click here for file Additional data file 7 Calculation of the distance difference matrix (Figure S9) Calculation of the distance difference matrix (Figure S9). Click here for file
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